A Safety and Immunogenicity of Intranasal Nanoemulsion Adjuvanted Recombinant Anthrax Vaccine in Healthy Adults

Condition:   Anthrax Interventions:   Biological: BW-1010: 50 µg - sprayer - IN;   Biological: BW-1010: 50 µg - pipette - IN;   Biological: BW-1010: 100 µg - sprayer - IN;   Biological: BW-1010: 100 µg - pipette - IN;   Biological: Saline (Placebo) - sprayer - IN;   Biological: Saline (Pl acebo) - pipette - IN;   Biological: BioThrax (positive control) - SC Sponsors:   BlueWillow Biologics;   Porton Biopharma Ltd. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials